109 related articles for article (PubMed ID: 34308204)
1. Reproductive and Lifestyle Characteristics of Kenyan Women Presenting With Precancerous Cervical Lesions: A Hospital-Based Case-Control Study.
Muitta E; Were T; Kebira AN
East Afr Health Res J; 2019; 3(2):115-124. PubMed ID: 34308204
[TBL] [Abstract][Full Text] [Related]
2. Atypical cervical cytomorphologic predictors: a descriptive study of pre-cervical cancer patients of low education in Kenya.
Muitta E; Were T; Nyamache AK; Muhoho N
Pan Afr Med J; 2019; 33():124. PubMed ID: 31558923
[TBL] [Abstract][Full Text] [Related]
3. Cervical Precancerous Lesions and Associated Factors Among Women Screened in Two Hospitals in the City of Douala, Cameroon.
Tagne Simo R; Mbock CV; Nwabo Kamdje AH; Djoko Nono AG; Nangue C; Telefo PB
Cureus; 2023 Jul; 15(7):e41993. PubMed ID: 37593257
[TBL] [Abstract][Full Text] [Related]
4. Prevaccination distribution of human papillomavirus types in women attending at cervical cancer screening in Belgium.
Arbyn M; Benoy I; Simoens C; Bogers J; Beutels P; Depuydt C
Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):321-30. PubMed ID: 19124515
[TBL] [Abstract][Full Text] [Related]
5. Progression Low Squamous Intraepithelial Lesion and Human Papillomavirus Infections.
Jahic M; Kameric L; Hadzimehmedovic A
Mater Sociomed; 2020 Jun; 32(2):127-130. PubMed ID: 32843861
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for cervical neoplasia in Denmark.
Kjaer SK
APMIS Suppl; 1998; 80():1-41. PubMed ID: 9693662
[TBL] [Abstract][Full Text] [Related]
7. Risk Factors Associated With Human Papillomavirus Infection, Cervical Cancer, and Precancerous Lesions in Large-Scale Population Screening.
Yang D; Zhang J; Cui X; Ma J; Wang C; Piao H
Front Microbiol; 2022; 13():914516. PubMed ID: 35847094
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis of Cervical Precancers by Endocervical Curettage at Colposcopy of Women With Abnormal Cervical Cytology.
Liu AH; Walker J; Gage JC; Gold MA; Zuna R; Dunn ST; Schiffman M; Wentzensen N
Obstet Gynecol; 2017 Dec; 130(6):1218-1225. PubMed ID: 29112672
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of high-risk human papillomavirus and cervical lesion risk factors: A population-based study in Zhejiang, China 2010-2019.
Lu W; Chen T; Yao Y; Chen P
J Med Virol; 2021 Aug; 93(8):5118-5125. PubMed ID: 33913528
[TBL] [Abstract][Full Text] [Related]
10. Cytology and high risk HPV testing in cervical cancer screening program: Outcome of 3-year follow-up in an academic institute.
Yang J; Nolte FS; Chajewski OS; Lindsey KG; Houser PM; Pellicier J; Wang Q; Ehsani L
Diagn Cytopathol; 2018 Jan; 46(1):22-27. PubMed ID: 29048733
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of High-Risk Human Papillomavirus Infection, Associated Risk Factors, and Relationship With Cervical Precancerous Lesions in Perimenopausal and Older Women in an Area With High Cervical Cancer Incidence in China.
Zhang R; Xu W; Yang S; Hu D; Bai L; Xiang R; Zhao X; Nie Y; Shi QL
Cureus; 2024 Apr; 16(4):e58081. PubMed ID: 38616979
[TBL] [Abstract][Full Text] [Related]
12. The prevelance of human papillomavirus (HPV) genotypes detected by PCR in women with normal and abnormal cervico-vaginal cytology.
Beyazit F; Sılan F; Gencer M; Aydin B; Paksoy B; Unsal MA; Ozdemir O
Ginekol Pol; 2018; 89(2):62-67. PubMed ID: 29512809
[TBL] [Abstract][Full Text] [Related]
13. [Analysis of clinical features of cervical precancerous lesions in postmenopausal women].
Liu YY; Guo RX; Li BJ; Wu Y; Bai J; Li LX; Wang CF
Zhonghua Fu Chan Ke Za Zhi; 2021 Feb; 56(2):114-120. PubMed ID: 33631883
[No Abstract] [Full Text] [Related]
14. The age-specific relationships of abnormal cytology and human papillomavirus DNA results to the risk of cervical precancer and cancer.
Castle PE; Fetterman B; Thomas Cox J; Shaber R; Poitras N; Lorey T; Kinney W
Obstet Gynecol; 2010 Jul; 116(1):76-84. PubMed ID: 20567171
[TBL] [Abstract][Full Text] [Related]
15. Squamous intraepithelial lesions (SIL: LSIL, HSIL, ASCUS, ASC-H, LSIL-H) of Uterine Cervix and Bethesda System.
Alrajjal A; Pansare V; Choudhury MSR; Khan MYA; Shidham VB
Cytojournal; 2021; 18():16. PubMed ID: 34345247
[TBL] [Abstract][Full Text] [Related]
16. Adjunctive high-risk human papillomavirus DNA testing is a useful option for disease risk assessment in patients with negative Papanicolaou tests without an endocervical/transformation zone sample.
Zhao C; Austin RM
Cancer; 2008 Aug; 114(4):242-8. PubMed ID: 18484643
[TBL] [Abstract][Full Text] [Related]
17. Variations in Progression and Regression of Precancerous Lesions of the Uterine Cervix on Cytology Testing Among Women of Different Races.
Martingano D; Renson A; Martingano AJ; Martingano FX
J Am Osteopath Assoc; 2018 Jan; 118(1):8-18. PubMed ID: 29309102
[TBL] [Abstract][Full Text] [Related]
18. Human papillomavirus infection and cervical cancer in Brazil: a retrospective study.
Cavalcanti SM; Deus FC; Zardo LG; Frugulhetti IC; Oliveira LH
Mem Inst Oswaldo Cruz; 1996; 91(4):433-40. PubMed ID: 9070405
[TBL] [Abstract][Full Text] [Related]
19. [Reliability of the CINtec p16INK4a immunocytochemical test in screening cervical precancerous lesions].
Jović M; Nenadić D; Magić Z; Zoltarevski L; Durdević-Vukomanović B; Tatomirović Z; Strelić N; Vojvodić D
Vojnosanit Pregl; 2008 Mar; 65(3):211-9. PubMed ID: 18494269
[TBL] [Abstract][Full Text] [Related]
20. Atypical squamous cells of undetermined significance and low-grade squamous intraepithelial lesion triage in Korean women: Revisiting the 2012 American Society of Colposcopy and Cervical Pathology screening guidelines.
Hyun JY; Min KJ; Yang SY; Lee JK; Hong JH
Obstet Gynecol Sci; 2017 Jul; 60(4):357-361. PubMed ID: 28791267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
